Standard BioTools Inc. originally originated under the name Fluidigm Corporation, a pioneering life sciences technology enterprise founded to develop innovative microfluidics and mass cytometry systems for single-cell biology research. Following strategic leadership shifts, corporate restructuring, and a major rebranding initiative to better reflect its broader life sciences portfolio, the company adopted the name Standard BioTools. In subsequent years, the enterprise engaged in targeted mergers and structural portfolio transformations—such as acquiring proteomics businesses and later divesting specific operating units—to focus on high-margin next-generation biomedical research tools.